Workflow
Stock price target revision
icon
Search documents
These Analysts Revise Their Forecasts On Costco After Q4 Results
Benzinga· 2025-09-26 15:50
Financial Performance - Costco reported fourth-quarter revenue of $86.16 billion, exceeding analyst estimates of $86.12 billion [1] - The company reported fourth-quarter adjusted earnings of $5.87 per share, surpassing estimates of $5.80 per share [1] Membership Fees - Membership fees reached approximately $1.72 billion, an increase from $1.51 billion in the same quarter last year [2] - The company raised its annual membership fee by $5 in September 2024, marking the first increase since 2017 [2] Stock Performance and Analyst Ratings - Following the earnings announcement, Costco shares fell 2% to $925.03 [2] - JP Morgan analyst Christopher Horvers maintained an Overweight rating but lowered the price target from $1,160 to $1,050 [7] - Bernstein analyst Zhihan Ma maintained an Outperform rating and raised the price target from $1,137 to $1,140 [7] - Truist Securities analyst Scot Ciccarelli maintained a Hold rating and lowered the price target from $1,042 to $1,033 [7]
Rothschild & Co sets Blackstone stock price target
Finbold· 2025-07-29 16:12
The revised target from Rothschild comes days after Keefe, Bruyette & Woods (KBW) also lifted its price target on Blackstone stock from $168 to $180, following the firm's stronger-than-expected quarterly earnings. On July 27, KBW cited higher-than-forecast fee-related earnings and net realizations as key drivers behind the $0.10 per-share earnings beat. Blackstone's 100% gross margin and 37% revenue growth over the past year were noted as evidence of its strong financial position. Blackstone stock (NYSE: BX ...
Banking giant revises Netflix stock price target
Finbold· 2025-05-13 14:24
Core Viewpoint - JPMorgan has raised its price target for Netflix stock from $1,025 to $1,150, reflecting a bullish outlook on the company's performance in the streaming industry [1][2]. Group 1: Stock Performance - As of the latest update, Netflix (NFLX) stock is trading at $1,112, with year-to-date (YTD) gains of 24.78%, significantly outperforming the S&P 500, which has seen a loss of 0.42% during the same period [3]. - The new price target implies a potential upside of 3.41% from the current stock price [3]. Group 2: Financial Projections - JPMorgan projects a 13% growth in foreign exchange neutral (FXN) revenue, a 22% increase in operating income, a 24% surge in GAAP earnings per share (EPS), and a 30% increase in free cash flow (FCF) for 2025 and 2026 [8]. - The revised price target of $1,150 is based on a 38x multiple of the projected 2026 EPS of $30.46, supporting a premium valuation for Netflix [8]. Group 3: Market Position and Risks - Netflix is recognized as a leader in the streaming industry, benefiting from its defensive subscription model, which provides a competitive advantage [2]. - Despite the bullish outlook, there are concerns regarding potential risks from proposed movie tariffs, although the impact remains uncertain [7].
Analysts set UnitedHealth stock price target
Finbold· 2025-04-18 12:43
Core Insights - UnitedHealth experienced a significant stock decline on April 17, prompting analysts to revise their price targets downward [1][3] - Despite the downgrades, analysts maintain 'buy' ratings for UnitedHealth stock, indicating potential upside [2] - The downward revisions were primarily due to UnitedHealth's earnings report, which missed revenue and EPS expectations, along with a lowered full-year forecast for 2025 [3] Group 1: Stock Performance - UnitedHealth stock plunged 22.38% in a single day, erasing previous recovery gains [5] - Year-to-date, UnitedHealth shares are down 10.23%, with a 9.86% decline over the past 30 days [6] Group 2: Analyst Revisions - Piper Sandler lowered its price target from $600 to $592, while Barclays reduced its target from $642 to $560 [1] - The new price targets suggest a 30.36% upside from Piper Sandler and a 23.32% upside from Barclays [2] Group 3: Earnings Report Impact - UnitedHealth reported revenue of $109.58 billion, missing the expected $111.60 billion [3] - The company announced an EPS of $7.20, below the anticipated $7.29, and revised its 2025 EPS forecast down to $26-$26.50 from $29.50-$30 [3] - The negative earnings report affected not only UnitedHealth but also other companies in the health sector, such as CVS Health and Humana [4]